Clinical trial

Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction

NCT05974566

Study summary

ClinicalTrials.gov

Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record above.

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2023-08-01

PhaseN/A

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Diabetes Mellitusverified · MONDO: diabetes mellitus

Diabetic Nephropathiesunresolved

Interventions

Sponsors & collaborators

Chongqing Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05974566 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.